Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.56
ABC's Cash to Debt is ranked lower than
55% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.65 vs. ABC: 0.56 )
Ranked among companies with meaningful Cash to Debt only.
ABC' s Cash to Debt Range Over the Past 10 Years
Min: 0.06  Med: 0.49 Max: 1.7
Current: 0.56
0.06
1.7
Equity to Asset 0.07
ABC's Equity to Asset is ranked lower than
96% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.40 vs. ABC: 0.07 )
Ranked among companies with meaningful Equity to Asset only.
ABC' s Equity to Asset Range Over the Past 10 Years
Min: -0.05  Med: 0.20 Max: 0.38
Current: 0.07
-0.05
0.38
Interest Coverage 12.99
ABC's Interest Coverage is ranked higher than
66% of the 41 Companies
in the Global Medical Distribution industry.

( Industry Median: 6.95 vs. ABC: 12.99 )
Ranked among companies with meaningful Interest Coverage only.
ABC' s Interest Coverage Range Over the Past 10 Years
Min: 4.09  Med: 13.82 Max: 60.07
Current: 12.99
4.09
60.07
F-Score: 6
Z-Score: 4.93
M-Score: -2.69
WACC vs ROIC
6.18%
44.92%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) 1.15
ABC's Operating margin (%) is ranked lower than
82% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 4.23 vs. ABC: 1.15 )
Ranked among companies with meaningful Operating margin (%) only.
ABC' s Operating margin (%) Range Over the Past 10 Years
Min: 0.31  Med: 1.23 Max: 1.58
Current: 1.15
0.31
1.58
Net-margin (%) 1.06
ABC's Net-margin (%) is ranked lower than
71% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.84 vs. ABC: 1.06 )
Ranked among companies with meaningful Net-margin (%) only.
ABC' s Net-margin (%) Range Over the Past 10 Years
Min: -0.1  Med: 0.71 Max: 0.9
Current: 1.06
-0.1
0.9
ROE (%) 99.32
ABC's ROE (%) is ranked higher than
98% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 9.54 vs. ABC: 99.32 )
Ranked among companies with meaningful ROE (%) only.
ABC' s ROE (%) Range Over the Past 10 Years
Min: -10.41  Med: 15.57 Max: 27.02
Current: 99.32
-10.41
27.02
ROA (%) 5.21
ABC's ROA (%) is ranked higher than
76% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.70 vs. ABC: 5.21 )
Ranked among companies with meaningful ROA (%) only.
ABC' s ROA (%) Range Over the Past 10 Years
Min: -0.55  Med: 3.81 Max: 4.8
Current: 5.21
-0.55
4.8
ROC (Joel Greenblatt) (%) 159.67
ABC's ROC (Joel Greenblatt) (%) is ranked higher than
96% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 22.70 vs. ABC: 159.67 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
ABC' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 40.04  Med: 133.46 Max: 177.95
Current: 159.67
40.04
177.95
Revenue Growth (3Y)(%) 26.40
ABC's Revenue Growth (3Y)(%) is ranked higher than
92% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 4.50 vs. ABC: 26.40 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
ABC' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 7.9  Med: 15.90 Max: 28.4
Current: 26.4
7.9
28.4
EBITDA Growth (3Y)(%) -19.40
ABC's EBITDA Growth (3Y)(%) is ranked lower than
86% of the 37 Companies
in the Global Medical Distribution industry.

( Industry Median: 7.90 vs. ABC: -19.40 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
ABC' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -19.4  Med: 15.30 Max: 26.8
Current: -19.4
-19.4
26.8
» ABC's 10-Y Financials

Financials (Next Earnings Date: 2016-08-02)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q3 2015

ABC Guru Trades in Q3 2015

Ray Dalio 47,443 sh (+12.04%)
Pioneer Investments Sold Out
Joel Greenblatt Sold Out
John Keeley 57,281 sh (-1.33%)
Ken Fisher 118,152 sh (-1.87%)
Jim Simons 781,200 sh (-28.02%)
Paul Tudor Jones 4,100 sh (-30.51%)
Jeremy Grantham 42,950 sh (-43.34%)
» More
Q4 2015

ABC Guru Trades in Q4 2015

George Soros 3,900 sh (New)
Jim Simons 1,410,100 sh (+80.50%)
Ray Dalio 58,485 sh (+23.27%)
Ken Fisher 112,848 sh (-4.49%)
Paul Tudor Jones 2,200 sh (-46.34%)
John Keeley 29,021 sh (-49.34%)
Jeremy Grantham 10,700 sh (-75.09%)
» More
Q1 2016

ABC Guru Trades in Q1 2016

Leucadia National 2,900 sh (New)
Joel Greenblatt 6,083 sh (New)
First Pacific Advisors 93,690 sh (New)
Ray Dalio 243,992 sh (+317.19%)
Paul Tudor Jones 5,000 sh (+127.27%)
Jeremy Grantham Sold Out
George Soros Sold Out
Ken Fisher 110,647 sh (-1.95%)
Jim Simons 1,239,400 sh (-12.11%)
John Keeley 14,490 sh (-50.07%)
» More
Q2 2016

ABC Guru Trades in Q2 2016

Arnold Van Den Berg 82,350 sh (New)
» More
» Details

Insider Trades

Latest Guru Trades with ABC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Distribution » Medical Distribution
Compare:NAS:HSIC, OTCPK:SHTDY, NYSE:CAH, OTCPK:SHPMY, NAS:PDCO, OTCPK:MAHLY, NYSE:PBH, NYSE:OMI, NYSE:PMC, OTCPK:ANNIF, OTCPK:SCVM, OTCPK:NPHC, NYSE:MCK » details
Traded in other countries:ABG.Germany,
AmerisourceBergen Corp is a pharmaceutical services company. It provides drug distribution and related healthcare services and solutions to pharmacy, physician, and manufacturer customers based in the United States and Canada.

AmerisourceBergen Corp was incorporated in Delaware in 2001. It is a pharmaceutical sourcing and distribution services company. It serves healthcare providers and pharmaceutical manufacturers in the pharmaceutical supply channel and provides drug distribution and related services designed to reduce costs and improve patient outcomes. The Company distributes a comprehensive offering of brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers mainly located in the United States and Canada, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical and dialysis clinics, physicians, long-term care and other alternate site pharmacies and other customers. It also provides pharmacy services to certain specialty drug patients. Additionally, it furnishes healthcare providers and pharmaceutical manufacturers with an assortment of related services including pharmaceutical packaging, pharmacy automation, inventory management, reimbursement and pharmaceutical consulting services, logistics services, and pharmacy management. It operates in United States and Canada. It currently serves its customers through a geographically diverse network of distribution service centers and other operations in the United States and Canada, and through packaging facilities in the United States and the United Kingdom. The Company's national competitors are Cardinal Health, Inc. and McKesson Corporation. It is subject to oversight by various federal and state governmental entities and it is subject to and affected by a variety of federal and state laws, regulations and policies.

Top Ranked Articles about AmerisourceBergen Corp

Ray Dalio Quadruples His Stake in AmerisourceBergen Company has multiple good signs in an industry that continues to grow worldwide
Ray Dalio (Trades, Portfolio) quadrupled his stake in AmerisourceBergen Corp. (NYSE:ABC) in the first quarter. The guru acquired 185,507 shares for an average price of $89.32 per share. Read more...
A Short-Term Problem Creates Long-Term Opportunity in Lannett Company Generic drug manufacturer is mispriced due to irrational fears
I use several different techniques to search for potential investment opportunities. But, there is no question that I strongly favor value investing because I like large margins of safety surrounding my money. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 12.65
ABC's P/E(ttm) is ranked higher than
90% of the 41 Companies
in the Global Medical Distribution industry.

( Industry Median: 22.64 vs. ABC: 12.65 )
Ranked among companies with meaningful P/E(ttm) only.
ABC' s P/E(ttm) Range Over the Past 10 Years
Min: 10.92  Med: 18.40 Max: 1317.44
Current: 12.65
10.92
1317.44
Forward P/E 14.22
ABC's Forward P/E is ranked higher than
67% of the 12 Companies
in the Global Medical Distribution industry.

( Industry Median: 14.47 vs. ABC: 14.22 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 12.65
ABC's PE(NRI) is ranked higher than
90% of the 41 Companies
in the Global Medical Distribution industry.

( Industry Median: 22.66 vs. ABC: 12.65 )
Ranked among companies with meaningful PE(NRI) only.
ABC' s PE(NRI) Range Over the Past 10 Years
Min: 9.93  Med: 16.15 Max: 1284.5
Current: 12.65
9.93
1284.5
Price/Owner Earnings (ttm) 4.68
ABC's Price/Owner Earnings (ttm) is ranked higher than
96% of the 26 Companies
in the Global Medical Distribution industry.

( Industry Median: 25.05 vs. ABC: 4.68 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
ABC' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 4.06  Med: 11.19 Max: 502.53
Current: 4.68
4.06
502.53
P/B 8.71
ABC's P/B is ranked lower than
98% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.23 vs. ABC: 8.71 )
Ranked among companies with meaningful P/B only.
ABC' s P/B Range Over the Past 10 Years
Min: 1.67  Med: 3.18 Max: 34.65
Current: 8.71
1.67
34.65
P/S 0.14
ABC's P/S is ranked higher than
89% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.90 vs. ABC: 0.14 )
Ranked among companies with meaningful P/S only.
ABC' s P/S Range Over the Past 10 Years
Min: 0.07  Med: 0.14 Max: 0.2
Current: 0.14
0.07
0.2
PFCF 5.35
ABC's PFCF is ranked higher than
95% of the 20 Companies
in the Global Medical Distribution industry.

( Industry Median: 19.46 vs. ABC: 5.35 )
Ranked among companies with meaningful PFCF only.
ABC' s PFCF Range Over the Past 10 Years
Min: 4.65  Med: 9.97 Max: 50.52
Current: 5.35
4.65
50.52
POCF 4.92
ABC's POCF is ranked higher than
96% of the 23 Companies
in the Global Medical Distribution industry.

( Industry Median: 15.17 vs. ABC: 4.92 )
Ranked among companies with meaningful POCF only.
ABC' s POCF Range Over the Past 10 Years
Min: 4.28  Med: 8.66 Max: 463.25
Current: 4.92
4.28
463.25
EV-to-EBIT 12.69
ABC's EV-to-EBIT is ranked higher than
72% of the 39 Companies
in the Global Medical Distribution industry.

( Industry Median: 15.95 vs. ABC: 12.69 )
Ranked among companies with meaningful EV-to-EBIT only.
ABC' s EV-to-EBIT Range Over the Past 10 Years
Min: -151.7  Med: 9.80 Max: 369.6
Current: 12.69
-151.7
369.6
EV-to-EBITDA 10.51
ABC's EV-to-EBITDA is ranked higher than
65% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.87 vs. ABC: 10.51 )
Ranked among companies with meaningful EV-to-EBITDA only.
ABC' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.9  Med: 9.10 Max: 906
Current: 10.51
5.9
906
Shiller P/E 43.39
ABC's Shiller P/E is ranked lower than
76% of the 17 Companies
in the Global Medical Distribution industry.

( Industry Median: 29.60 vs. ABC: 43.39 )
Ranked among companies with meaningful Shiller P/E only.
ABC' s Shiller P/E Range Over the Past 10 Years
Min: 16.19  Med: 28.86 Max: 84.91
Current: 43.39
16.19
84.91
Current Ratio 0.93
ABC's Current Ratio is ranked lower than
92% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.58 vs. ABC: 0.93 )
Ranked among companies with meaningful Current Ratio only.
ABC' s Current Ratio Range Over the Past 10 Years
Min: 0.85  Med: 1.26 Max: 1.74
Current: 0.93
0.85
1.74
Quick Ratio 0.48
ABC's Quick Ratio is ranked lower than
98% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.13 vs. ABC: 0.48 )
Ranked among companies with meaningful Quick Ratio only.
ABC' s Quick Ratio Range Over the Past 10 Years
Min: 0.37  Med: 0.52 Max: 0.68
Current: 0.48
0.37
0.68
Days Inventory 26.63
ABC's Days Inventory is ranked higher than
81% of the 47 Companies
in the Global Medical Distribution industry.

( Industry Median: 48.45 vs. ABC: 26.63 )
Ranked among companies with meaningful Days Inventory only.
ABC' s Days Inventory Range Over the Past 10 Years
Min: 22.26  Med: 24.81 Max: 26.6
Current: 26.63
22.26
26.6
Days Sales Outstanding 22.52
ABC's Days Sales Outstanding is ranked higher than
86% of the 43 Companies
in the Global Medical Distribution industry.

( Industry Median: 54.55 vs. ABC: 22.52 )
Ranked among companies with meaningful Days Sales Outstanding only.
ABC' s Days Sales Outstanding Range Over the Past 10 Years
Min: 17.26  Med: 19.23 Max: 25.11
Current: 22.52
17.26
25.11
Days Payable 60.71
ABC's Days Payable is ranked lower than
58% of the 38 Companies
in the Global Medical Distribution industry.

( Industry Median: 69.49 vs. ABC: 60.71 )
Ranked among companies with meaningful Days Payable only.
ABC' s Days Payable Range Over the Past 10 Years
Min: 39.24  Med: 43.91 Max: 57.57
Current: 60.71
39.24
57.57

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.54
ABC's Dividend Yield is ranked lower than
52% of the 54 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.42 vs. ABC: 1.54 )
Ranked among companies with meaningful Dividend Yield only.
ABC' s Dividend Yield Range Over the Past 10 Years
Min: 0.11  Med: 0.99 Max: 1.71
Current: 1.54
0.11
1.71
Dividend Payout 0.18
ABC's Dividend Payout is ranked higher than
79% of the 34 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.29 vs. ABC: 0.18 )
Ranked among companies with meaningful Dividend Payout only.
ABC' s Dividend Payout Range Over the Past 10 Years
Min: 0.02  Med: 0.12 Max: 1.12
Current: 0.18
0.02
1.12
Dividend Growth (3y) 30.70
ABC's Dividend Growth (3y) is ranked higher than
88% of the 25 Companies
in the Global Medical Distribution industry.

( Industry Median: 13.20 vs. ABC: 30.70 )
Ranked among companies with meaningful Dividend Growth (3y) only.
ABC' s Dividend Growth (3y) Range Over the Past 10 Years
Min: 0  Med: 29.80 Max: 81.7
Current: 30.7
0
81.7
Forward Dividend Yield 1.60
ABC's Forward Dividend Yield is ranked lower than
56% of the 50 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.94 vs. ABC: 1.60 )
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield on cost (5-Year) 5.75
ABC's Yield on cost (5-Year) is ranked higher than
78% of the 54 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.94 vs. ABC: 5.75 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
ABC' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0.41  Med: 3.72 Max: 6.42
Current: 5.75
0.41
6.42
3-Year Average Share Buyback Ratio 4.20
ABC's 3-Year Average Share Buyback Ratio is ranked higher than
97% of the 31 Companies
in the Global Medical Distribution industry.

( Industry Median: -1.10 vs. ABC: 4.20 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
ABC' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -24  Med: 4.30 Max: 9.9
Current: 4.2
-24
9.9

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 0.74
ABC's Price/Projected FCF is ranked higher than
88% of the 26 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.30 vs. ABC: 0.74 )
Ranked among companies with meaningful Price/Projected FCF only.
ABC' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.32  Med: 0.81 Max: 8.94
Current: 0.74
0.32
8.94
Price/Median PS Value 0.97
ABC's Price/Median PS Value is ranked higher than
60% of the 42 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.04 vs. ABC: 0.97 )
Ranked among companies with meaningful Price/Median PS Value only.
ABC' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.5  Med: 1.03 Max: 1.81
Current: 0.97
0.5
1.81
Earnings Yield (Greenblatt) (%) 7.99
ABC's Earnings Yield (Greenblatt) (%) is ranked higher than
76% of the 45 Companies
in the Global Medical Distribution industry.

( Industry Median: 6.00 vs. ABC: 7.99 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
ABC' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 0.3  Med: 10.00 Max: 15
Current: 7.99
0.3
15
Forward Rate of Return (Yacktman) (%) -13.50
ABC's Forward Rate of Return (Yacktman) (%) is ranked lower than
94% of the 31 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.88 vs. ABC: -13.50 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
ABC' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -22  Med: 17.50 Max: 29.5
Current: -13.5
-22
29.5

More Statistics

Revenue (TTM) (Mil) $142,111
EPS (TTM) $ 6.75
Beta0.74
Short Percentage of Float5.78%
52-Week Range $73.31 - 109.08
Shares Outstanding (Mil)215.85

Analyst Estimate

Sep16 Sep17 Sep18
Revenue (Mil $) 147,227 160,792 173,773
EPS ($) 5.56 6.06 7.15
EPS w/o NRI ($) 5.56 6.06 7.15
EPS Growth Rate
(3Y to 5Y Estimate)
N/A
Dividends Per Share ($) 1.11 1.21 1.30
» More Articles for ABC

Headlines

Articles On GuruFocus.com
Sometimes It Is Good to Buy the Biggest. But Should You Buy the Biggest Health Care Distribution Bus Jul 29 2016 
Arnold Van Den Berg 2nd Quarter: Cuts Back on Gold Miners, Gets More Bullish on Oil Jul 25 2016 
Van Den Berg Made 6 New Buys in 2nd Quarter Jul 24 2016 
Beware the Financial Destruction of Overvaluation Jun 02 2016 
Ray Dalio Quadruples His Stake in AmerisourceBergen Jun 01 2016 
A Short-Term Problem Creates Long-Term Opportunity in Lannett Company Jan 12 2016 
Walgreens Buys Rite Aid to Avoid Loose Market Nov 04 2015 
The Case for Investing in AmerisourceBergen Aug 13 2015 
Why Hedge Funds Are Betting On AmerisourceBergen Apr 10 2015 
Apple TV And Online TV Service Will Be Released This Year Mar 24 2015 

More From Other Websites
Adelaide Brighton Ltd. :ABC-AU: Earnings Analysis: For the six months ended December 31, 2015 : July... Jul 26 2016
Adelaide Brighton Ltd. :ABC-AU: Earnings Analysis: 2015 By the Numbers : July 22, 2016 Jul 22 2016
Coverage Initiated on Select Services Stocks Jul 18 2016
Dividend Champions and Contenders That Appear Enticingly Valued Jul 15 2016
NBC's 'Funded' Taking On ABC's 'Shark Tank?' Jul 14 2016
FOX Orders New X-Men TV Series From Marvel (Unfortunately) Jul 13 2016
Evaluating Walgreen’s Performance in Fiscal 3Q16 Jul 08 2016
Walgreens' Recent Dip Provides Opportunity as Long-Term Catalysts Remain Jul 06 2016
AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2016 Earnings Release Jul 05 2016
5 Cheap Value Stocks for Investors in July Jul 05 2016
AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2016 Earnings Release Jul 05 2016
AmerisourceBergen Corp. – Value Analysis (NYSE:ABC) : July 5, 2016 Jul 05 2016
Exploring WBA’s Fiscal 2Q16 ahead of Its Fiscal 3Q16 Earnings Jul 01 2016
AmerisourceBergen Corp. breached its 50 day moving average in a Bullish Manner : ABC-US : July 1,... Jul 01 2016
AMERISOURCEBERGEN CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a... Jun 23 2016
ETF’s with exposure to AmerisourceBergen Corp. : June 20, 2016 Jun 20 2016
AMERISOURCEBERGEN CORP Files SEC form 8-K, Regulation FD Disclosure Jun 15 2016
Premarket Research Report Covering the Services Sector Jun 14 2016
AmerisourceBergen seen holding firm Jun 10 2016
Beware the Financial Destruction of Overvaluation Jun 02 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)